Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Impact BioMedical, Inc. ( (IBO) ) is now available.
On July 21, 2025, Impact BioMedical Inc. entered into a Debt Conversion Agreement with DSS, Inc. to settle a $12 million loan originally made in March 2023. The agreement involves the issuance of 31,939,778 shares of common stock to DSS, fully satisfying the debt and any additional financial support provided by DSS up to the transaction’s closing.
More about Impact BioMedical, Inc.
Average Trading Volume: 11,314,788
Technical Sentiment Signal: Strong Sell
For an in-depth examination of IBO stock, go to TipRanks’ Overview page.